The International Journal of Romanian Society of Endocrinology / Registered in 1938

in Web of Science Master Journal List

Acta Endocrinologica(Bucharest) is live in PubMed Central

Journal Impact Factor - click here.

July - September 2021, Volume 17, Issue 3
General Endocrinology

Demiral M, Kiraz ZK, Alatas IO, Cetin N, Kirel B

Pseudo-Hyperthyroidism: Biotin Interference in a Case with Renal Failure

Acta Endo (Buc) 2021, 17 (3): 319-322
doi: 10.4183/aeb.2021.319

Introduction. Biotin treatment causes false-low or false-high results in some immunoassays methods. This phenomenon is called as biotin interference. In the present article, a seven-month-old male, with renal failure and laboratory hyperthyroidism due to biotin interference is presented. Case report. High free T4 (fT4), free T3 (fT3), antithyroid peroxidase antibody (anti-TPO), anti-thyroglobulin antibody (anti-TG) and low thyroid stimulating hormone (TSH) levels were detected in a seven-month-old male patient who has metabolic acidosis, renal failure, and suspected of metabolic disease. Anti-thyroid drug therapy was started. However, when he was re-evaluated due to the absence of euthyroidism with anti-thyroid therapy (methimazole 0.8 mg/ kg /day), it was found that the patient had been given 20 mg/ day biotin for acidosis for two months. Biotin interference was considered in hormone measurement. Thyroid function tests were found to be normal 12 days after discontinuation of biotin therapy. Conclusion. Immunoassay measurements which use biotin should be done 2-7days after the last dose of biotin in patients under biotin treatment, but this time may need be much longer in renal failure patients. During this period or if the biotin therapy cannot be stopped, alternative methods should be preferred for analysis.

Keywords: biotin interference, renal failure, pseudo-hyperthyroidism.

Correspondence: Meliha Demiral MD, Pediatric Endocrinology, Balikesir Atatürk City Hospital, Balikesir, Turkey, E-mail: drmelihad@